Gao HL - Search Results

1

[Chemotherapy risk assessment for elderly patients].

Gao HL, Bai CM. Gao HL, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Oct;36(5):551-5. doi: 10.3881/j.issn.1000-503X.2014.05.019. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014. PMID: 25360657 Review. Chinese.

2

High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.

Gao H, Guan M, Sun Z, Bai C. Gao H, et al. Tumour Biol. 2015 Feb;36(2):515-20. doi: 10.1007/s13277-014-2659-5. Epub 2015 Jan 31. Tumour Biol. 2015. PMID: 25636446 Review.

3

KLF17 Expression in Colorectal Carcinoma and Its Clinical Significance.

Gao HL, Zhou N, Sun Z, Dou XL, Guan M, Bai CM. Gao HL, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Feb;38(1):69-72. doi: 10.3881/j.issn.1000-503X.2016.01.012. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 26956859

4

Efficiency of Sunitinib in Chinese Patients with Advanced Progressive Pancreatic Neuroendocrine Tumor.

Gao HL, Ying HY, Cheng YJ, Meng CT, Bai CM. Gao HL, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Jun 10;38(3):300-4. doi: 10.3881/j.issn.1000-503X.2016.03.010. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 27469915

5

Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.

Song YL, Yu R, Qiao XW, Bai CM, Lu CM, Xiao Y, Zhong DR, Chen J, Zhao YP, Zhang TP, Song TT, Gao HL, Wan YH, Shen L, Chen J, Lv B, Hao JJ, Zhang Y, Tang L, Chen YJ. Song YL, et al. Among authors: gao hl. Sci Rep. 2017 May 19;7(1):2205. doi: 10.1038/s41598-017-02051-1. Sci Rep. 2017. PMID: 28526880 Free PMC article.

6

The expression of versican and its role in pancreatic neuroendocrine tumors.

Gao H, Cheng Y, Chen Y, Luo F, Shao Y, Sun Z, Bai C. Gao H, et al. Pancreatology. 2020 Jan;20(1):142-147. doi: 10.1016/j.pan.2019.11.009. Epub 2019 Nov 20. Pancreatology. 2020. PMID: 31771905

7

Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors.

Gao H, Dong J, Zhang W, Xu H, Ye L, Li H, Ni Q, Wang W, Liu L. Gao H, et al. Endocr Pract. 2022 Mar;28(3):292-297. doi: 10.1016/j.eprac.2021.08.008. Epub 2021 Aug 25. Endocr Pract. 2022. PMID: 34454077

8

The optimal duration of capecitabine plus temozolomide in patients with well-differentiated pancreatic NETs with or without maintenance therapy.

Gao H, Dong J, Zhang W, Xu H, Ye L, Li H, Wang W, Liu L, Yu X. Gao H, et al. J Neuroendocrinol. 2022 Jun;34(6):e13112. doi: 10.1111/jne.13112. Epub 2022 Apr 5. J Neuroendocrinol. 2022. PMID: 35380016

9

Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.

Han X, Zhang WH, Gao HL, Li TJ, Xu HX, Li H, Li PC, Wang X, Yu XJ, Wang WQ, Liu L. Han X, et al. Among authors: gao hl. J Clin Lab Anal. 2022 Jul;36(7):e24517. doi: 10.1002/jcla.24517. Epub 2022 May 27. J Clin Lab Anal. 2022. PMID: 35622458 Free PMC article.

10

Angiogenesis in pancreatic cancer: current research status and clinical implications.

Li S, Xu HX, Wu CT, Wang WQ, Jin W, Gao HL, Li H, Zhang SR, Xu JZ, Qi ZH, Ni QX, Yu XJ, Liu L. Li S, et al. Among authors: gao hl. Angiogenesis. 2019 Feb;22(1):15-36. doi: 10.1007/s10456-018-9645-2. Epub 2018 Aug 24. Angiogenesis. 2019. PMID: 30168025 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page